Cargando…
Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
SUMMARY: This retrospective study reports 81% long-term (> 3 years) adherence to and 77% persistence with zoledronic acid (ZA) treatment in osteoporosis patients, with ZA being costfree for patients. Eight percent of patients discontinued treatment because of adverse events (AEs), with a tendency...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165128/ https://www.ncbi.nlm.nih.gov/pubmed/32303862 http://dx.doi.org/10.1007/s11657-020-00733-4 |